Posted on 16 August 2024

Natalia Elizalde discusses key trends from ASGCT 2024 annual meeting in Baltimore

Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, answered some questions for The Medicine Maker around the trends and key topics that were covered throughout American Society of Gene & Cell Therapy´s (ASGCT) annual meeting that took place last May in Baltimore.

In addition to Natalia, The Medicine Maker interviewed Stuart Gibb, Ph.D from Terumo Blood and Cell Technologies, Gabrielle Freitas from OrganaBio, Matthew Paterson from eXmoor Pharma, and George Buchman PhD from Catalent Pharma Solutions, to uncover what sparked the most enthusiasm and to envision what a bold new future might hold.

Thank you all for sharing your views, and many thanks to The Medicine Maker for the great piece. You can read it here: https://themedicinemaker.com/manufacture/vector-connector